Northern Trust’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Northern Trust’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-512,868	Closed	-$88.6M	–	4360
2015 Q1	$88.6M	Sell	512,868 -110,899	-18%	-$16.3M	0.03%	564
2014 Q4	$71.7M	Buy	623,767 +85,642	+16%	+$10.4M	0.02%	631
2014 Q3	$84.1M	Buy	538,125 +28,980	+6%	+$4.2M	0.03%	534
2014 Q2	$62.8M	Sell	509,145 -70,571	-12%	-$7.8M	0.02%	666
2014 Q1	$60.1M	Buy	579,716 +93,349	+19%	+$9.56M	0.02%	712
2013 Q4	$43.7M	Buy	486,367 +9,192	+2%	+$733K	0.01%	862
2013 Q3	$31.9M	Buy	477,175 +126,997	+36%	+$8.75M	0.01%	1052
2013 Q2	$23.2M	Buy	+350,178	New	+$20M	0.01%	1262

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Northern Trust's SLXP Position: Q2 2015 in Review

Northern Trust sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 512,868 shares — an estimated $88.6M sold.

Northern Trust first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $88.6M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Northern Trust reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Northern Trust sold 512,868 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $88.6M.
Northern Trust first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Northern Trust's SALIX PHARMACEUTICALS LTD DEL position peaked at $88.6M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Northern Trust's 13F filing for Q2 2015, filed 13 Aug 2015.